Overview
- Hess Midstream reported EPS of $0.75 versus $0.73 expected and adjusted EBITDA of $321 million, with gas processing at about 462 mmcf/d.
- Management suspended the Capa/Kappa gas plant, cutting 2025 capex to roughly $270 million and lifting adjusted free cash flow to $760–$770 million, supporting a higher distribution alongside a $100 million repurchase.
- Hess said Chevron is running three rigs in the Bakken with oil expected to plateau and gas to rise over time, and it will publish 2026 guidance and 2028 MVCs after the December budget process.
- Pediatrix delivered EPS of $0.838 versus $0.46 expected, adjusted EBITDA of $87 million and $138 million in operating cash flow, ending Q3 with $340 million in cash and net leverage just under 1x.
- Stronger pricing and collections drove Pediatrix performance, with same‑unit growth near 8%, Q3 buybacks of 1.2 million shares plus modest acquisitions, and a full‑year adjusted EBITDA outlook of $270–$290 million reflecting year‑end variability.